| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US10314790 | SUPERNUS PHARMS | Sustained-release formulations of topiramate |
Nov, 2027
(3 years from now) | |
| US9622983 | SUPERNUS PHARMS | Sustained-release formulations of topiramate |
Nov, 2027
(3 years from now) | |
| US8992989 | SUPERNUS PHARMS | Sustained-release formulations of topiramate |
Nov, 2027
(3 years from now) | |
| US8663683 | SUPERNUS PHARMS | Sustained-release formulations of topiramate |
Nov, 2027
(3 years from now) | |
| US9549940 | SUPERNUS PHARMS | Sustained-release formulations of topiramate |
Nov, 2027
(3 years from now) | |
| US8298580 | SUPERNUS PHARMS | Sustained-release formulations of topiramate |
Nov, 2027
(3 years from now) | |
| US8877248 | SUPERNUS PHARMS | Sustained-release formulations of topiramate |
Nov, 2027
(3 years from now) | |
| US9555004 | SUPERNUS PHARMS | Sustained-release formulations of topiramate |
Nov, 2027
(3 years from now) | |
| US8889191 | SUPERNUS PHARMS | Sustained-release formulations of topiramate |
Nov, 2027
(3 years from now) | |
| US8298576 | SUPERNUS PHARMS | Sustained-release formulations of topiramate |
Apr, 2028
(3 years from now) | |
Trokendi Xr is owned by Supernus Pharms.
Trokendi Xr contains Topiramate.
Trokendi Xr has a total of 10 drug patents out of which 0 drug patents have expired.
Trokendi Xr was authorised for market use on 16 August, 2013.
Trokendi Xr is available in capsule, extended release;oral dosage forms.
Trokendi Xr can be used as treatment of epilepsy, use of trokendi xr for the treatment of epilepsy, use of trokendi xr for prophylactic treatment of migraine.
The generics of Trokendi Xr are possible to be released after 04 April, 2028.
Drugs and Companies using TOPIRAMATE ingredient
Market Authorisation Date: 16 August, 2013
Treatment: Use of trokendi xr for the treatment of epilepsy; Use of trokendi xr for prophylactic treatment of migraine; Treatment of epilepsy
Dosage: CAPSULE, EXTENDED RELEASE;ORAL
TROKENDI XR family patents
